Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Enzolytics Inc
ENZC
Healthcare
Biotechnology
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies...
: Immunotherapy, immune modulators, fully human monoclonal antibodies and an artificial intelligence (AI) platform for heath care developments. The Company has clinically tested anti HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:ENZC)
New Post
View:
Posts & Comments
Threaded Posts
(1)
•••
Williaminvestor
X
Post by
Williaminvestor
on May 15, 2023 9:55am
Undervalued Biotech Stocks to Watch
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:$ENZC) 300% Run: $RMED, $SPPI, $HALB, $VXRT https://www.marketwatch.com/press-release/undervalued-biotech-stocks-to-watch-after-enzolytics
...more
(0)
•••
Djritzz
X
Post by
Djritzz
on Feb 17, 2022 9:55am
On track for product on shelves by march!!
https://www.digitaljournal.com/pr/enzolytics-ipf-immune-is-the-perfect-choice-for-people-with-weakened-immune-systems#ixzz7L5P5KBMX
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Jun 11, 2021 8:39am
$ELZC 5 Reasons Why Enzolytics is a Compelling Choice!
5 Reasons Why Enzolytics is a Compelling Choice! 5 Reasons Why Enzolytics is a Compelling Choice!
(19)
•••
Goldnboy1
X
Post by
Goldnboy1
on Mar 16, 2021 10:16am
Next ENZC minus the selloff
$apc.v Get long. You'll be happy you did. Some biggggg $$$ circling it!!
(15)
•••
Towser7
X
Post by
Towser7
on Feb 05, 2021 10:42pm
Seriously?
Nobody is posting on this? Fascinating company with a promising HIV drug.
(0)
•••
Dayngerdabs
X
Post by
Dayngerdabs
on Jan 13, 2021 2:31am
ENZC and BSSP
$ENZC if you follow ENZC , You need to follow and look into $BSSP , these companies have the same board of directors , and bssp submitted for an FDA approval. Look into NDA 1168 , immunotherapy drug
...more
(0)
•••
Dayngerdabs
X
Post by
Dayngerdabs
on Jan 10, 2021 7:44pm
ENZC and BSSP
$ENZC if you follow ENZC , You need to follow and look into $BSSP , these companies have the same board of directors , and bssp submitted for an FDA approval. Look into NDA 1168 , immunotherapy drug
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
Featured News Links
Green Metals Royalty Company: "The Perfect Junior Mining Investment?" - Read More Here
Milestone Agreement for Developing Radiology Drugs Announced
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report